Among patients with stable angina, percutaneous coronary intervention (PCI) is often performed to reduce symptoms. Whether this intervention is effective without the use of background antianginal medication is unknown. Full ORBITA-2 Research Summary: https://t.co/o23lFeHgWA
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Nov 2023 – Aug 2025Where it's discussed
-
X / Twitter173 posts
-
News36 articles
-
Facebook6 posts
-
YouTube4 videos
-
Blogs2 articles
AI synopsis
What people are saying
The comments reflect a balanced recognition of the trial's significance, citing examples such as mentions of the trial demonstrating symptom relief with PCI and debates over its clinical value, using words like 'important,' 'marvellous proof,' and 'seminal' to convey moderate impact and engagement. The overall tone indicates cautious interest and recognition of the trial's role in shaping cardiology discussions.
The majority of discussions acknowledge the trial's significance but show mixed opinions on the clinical implications, reflecting some disagreement about the benefits of PCI based on different interpretations.
Most posts demonstrate moderate curiosity, referencing the trial and its findings but not delving deeply into methodological details or broader debates.
Several discussions involve sharing summaries, commenting on the trial's importance, and expressing opinions, indicating active but not deeply analytical engagement.
The discussions highlight that the trial influences clinical perspectives and ongoing debates but do not suggest a radical shift in practice yet.
Abstract in brief
- A study was done to see if a procedure called PCI helps people with stable angina (chest pain) feel better than a fake (placebo) procedure.
- 301 patients were divided into two groups: one had the PCI and the other had the fake procedure for 12 weeks.
- The results showed that those who had PCI had better scores for their angina symptoms, meaning they felt less pain compared to the placebo group.
Top posts
Most liked on X and BlueskyOriginal Article: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2 trial) https://t.co/o23lFeHgWA #AHA23 @AHAScience https://t.co/QTk9UJhJ2G
Original Article: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2) https://t.co/o23lFeHgWA Editorial: Changing the Orbit around Percutaneous Coronary Intervention for Stable Angina https://t.co/4MiSm48LVa
1/
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina: @NEJM ORBITA-II Great research from @AHA_Research #AHA23 Summary
All mentions
Spironolactone's Impact on Heart Failure Outcomes
This week, John Mandrola MD discusses the significant findings of a study involving 1,663 patients with severe heart failure. The research shows that spironolactone, when added to standard treatment, can reduce death…
Efficacy of Percutaneous Coronary Intervention for Stable Angina
A study examined whether PCI improves symptoms in stable angina patients more than a placebo. Results indicate PCI reduces angina pain more effectively than the fake procedure over 12 weeks.
Top Clinical Papers of November 2023 in Cardiology
Join our scientific team as we discuss the three most impactful clinical papers of November 2023. This month’s highlights include a study on dapagliflozin in myocardial infarction without diabetes, showcasing its…
Effectiveness of DOACs in Atrial Fibrillation Management
This week’s podcast reviews significant trials including NOAH-AFNET 6 and ARTESiA that highlight the role of direct oral anticoagulants (DOACs) in preventing ischemic stroke among patients with device-detected atrial…
@PrashSanders @thecsanz 2/ ORBITA-2: In angina patients with proven ischaemia, despite complete revascularization ( in 149 of 151 PCI subjects) of the target vessels, 59% still had angina. There's lot still have to understand about the heart. https://t.co/4z9lPVjpew https://t.co/LSrRAwRlao
@drjohnm @CommunityNotes @DavidLBrownMD @AndrewFoy82 @RFRedberg @bogdienache Orbita 2 - https://t.co/60a4OpOSIt 90% vs 70% in your study is worth noting +/- degree of collateralization +/- atypical symptoms or exceptional symptoms (not discussed at length and often nuanced) Your suggestion that this was wrong is bot conclusive and you know that only few
@AlphaBetaAnil https://t.co/qVwcQiXCvv If patient has angina - you can treat with PCI for “symptoms only - Not for survival - at best you can argue your patient has ischemia in all 3 territories . However, bottomline is he is “asymptomatic” see below
RT @AAlMohammad87: Today I reviewed once again the important #ORBITA_2 trial @NEJM @rallamee #CardioTwitter Thank you @rallamee for taking…
Today I reviewed once again the important #ORBITA_2 trial @NEJM @rallamee #CardioTwitter Thank you @rallamee for taking on these challenges https://t.co/WyYmOXtyR6
RT @AkivaRosenzveig: 1/
RT @MedicinaSAM:
RT @ICigalini: #EAPCIJournalClub tomorrow!!! ➡️ORBITA-2 Trial (https://t.co/CL2M5qCDsG)
RT @ICigalini: #EAPCIJournalClub tomorrow!!! ➡️ORBITA-2 Trial (https://t.co/CL2M5qCDsG)
#EAPCIJournalClub tomorrow!!! ➡️ORBITA-2 Trial (https://t.co/CL2M5qCDsG)
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
さて、今夜私が頂くのは、 A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina | New England Journal of Medicine https://t.co/ahVyxkZqno
RT @AkivaRosenzveig: 1/
RT @AkivaRosenzveig: 1/
RT @AkivaRosenzveig: 1/
RT @AkivaRosenzveig: 1/
RT @AkivaRosenzveig: 1/
RT @AkivaRosenzveig: 1/
RT @AkivaRosenzveig: 1/
RT @AkivaRosenzveig: 16/ Now that we have a better understanding of how #ORBITA2 blinded their patients, join @CardioNerds #HouseJones and…
RT @AkivaRosenzveig: 1/
RT @AkivaRosenzveig: 16/ Now that we have a better understanding of how #ORBITA2 blinded their patients, join @CardioNerds #HouseJones and…
RT @AkivaRosenzveig: 1/
RT @AkivaRosenzveig: 1/
RT @AkivaRosenzveig: 1/
RT @AkivaRosenzveig: 1/
RT @AkivaRosenzveig: 1/
RT @AkivaRosenzveig: 16/ Now that we have a better understanding of how #ORBITA2 blinded their patients, join @CardioNerds #HouseJones and…
RT @AkivaRosenzveig: 1/
16/ Now that we have a better understanding of how #ORBITA2 blinded their patients, join @CardioNerds #HouseJones and our experts at 8PM EST tonight, February 29th for #CardsJC to discuss the takeaways from #ORBITA2 https://t.co/ig1BAnikVl https://t.co/wDcXIecN7F
1/
RT @LandmarkTrials: The ORBITA-2 trial demonstrated that PCI was more effective than a placebo procedure at reducing anginal symptoms among…
RT @LandmarkTrials: The ORBITA-2 trial demonstrated that PCI was more effective than a placebo procedure at reducing anginal symptoms among…
RT @LandmarkTrials: The ORBITA-2 trial demonstrated that PCI was more effective than a placebo procedure at reducing anginal symptoms among…
The ORBITA-2 trial demonstrated that PCI was more effective than a placebo procedure at reducing anginal symptoms among patients with stable angina. Full article: https://t.co/YFHbSxsHMG #Cardiotwitter #Cardiology #EBM #MedTwitter
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina ORBITA-2 https://t.co/O3FgpNIS6J
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina | NEJM https://t.co/cvsbE5Ze16
https://t.co/d0x181kP95
RT @shci_sec: Nuevo estudio para el debate en @NEJM. El ICP demuestra reducir síntomas de angina en pacientes sin medicación antianginosa p…
【NEJM】ORBITA2 PCI vs shamにランダム割り付けしたところ、12週経過後のangina symptom scoreはPCI群で2.1、sham群で5.6(OR 2.21, 1.41-3.47)。 治療前2週間は抗狭心症薬は中断(心不全などの別の適応症の薬は継続)。これ色々面白いな‥ #m勉 https://t.co/AFeG7kgjcf
RT @MedicinaSAM:
RT @shci_sec: Nuevo estudio para el debate en @NEJM. El ICP demuestra reducir síntomas de angina en pacientes sin medicación antianginosa p…
RT @shci_sec: Nuevo estudio para el debate en @NEJM. El ICP demuestra reducir síntomas de angina en pacientes sin medicación antianginosa p…
RT @shci_sec: Nuevo estudio para el debate en @NEJM. El ICP demuestra reducir síntomas de angina en pacientes sin medicación antianginosa p…
RT @shci_sec: Nuevo estudio para el debate en @NEJM. El ICP demuestra reducir síntomas de angina en pacientes sin medicación antianginosa p…
Nuevo estudio para el debate en @NEJM. El ICP demuestra reducir síntomas de angina en pacientes sin medicación antianginosa previa en comparación a placebo. #cardiología #PCI #investigaciónmédica https://t.co/y89rk4N8xC
RT @NEJM: Original Article: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2) https://t.co/o23l…
RT @NEJM: Original Article: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2) https://t.co/o23l…
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina
【安定狭心症の症状軽減にPCIは有効か(NEJM)】 安定狭心症患者、抗狭心症薬すべて中止301人、PCI vs プラセボRCT12週観察。狭心症症状スコアは 2.9 vs 5.6(オッズ比 2.21)と有意に改善。 プラセボは鎮静だけという試験デザイン、、、 参加者に感謝しかないですね。 https://t.co/Ab2I8zc07T https://t.co/MlqCKkPaXB
RT @NEJM: Original Article: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2) https://t.co/o23l…
RT @FAPsGal: Un ensayo controlado con placebo de #IntervenciónCoronariaPercutánea para la angina estable. Pacientes con angina estable
RT @NEJM: Among patients with stable angina, percutaneous coronary intervention (PCI) is often performed to reduce symptoms. Whether this i…
RT @NEJM: Among patients with stable angina, percutaneous coronary intervention (PCI) is often performed to reduce symptoms. Whether this i…
RT @NEJM: Among patients with stable angina, percutaneous coronary intervention (PCI) is often performed to reduce symptoms. Whether this i…
RT @NEJM: Among patients with stable angina, percutaneous coronary intervention (PCI) is often performed to reduce symptoms. Whether this i…
RT @NEJM: Among patients with stable angina, percutaneous coronary intervention (PCI) is often performed to reduce symptoms. Whether this i…
RT @FAPsGal: Un ensayo controlado con placebo de #IntervenciónCoronariaPercutánea para la angina estable. Pacientes con angina estable
Un ensayo controlado con placebo de #IntervenciónCoronariaPercutánea para la angina estable. Pacientes con angina estable
RT @NEJM: Among patients with stable angina, percutaneous coronary intervention (PCI) is often performed to reduce symptoms. Whether this i…
RT @NEJM: Among patients with stable angina, percutaneous coronary intervention (PCI) is often performed to reduce symptoms. Whether this i…
RT @NEJM: Among patients with stable angina, percutaneous coronary intervention (PCI) is often performed to reduce symptoms. Whether this i…
RT @NEJM: Among patients with stable angina, percutaneous coronary intervention (PCI) is often performed to reduce symptoms. Whether this i…
RT @NEJM: Among patients with stable angina, percutaneous coronary intervention (PCI) is often performed to reduce symptoms. Whether this i…
RT @NEJM: Among patients with stable angina, percutaneous coronary intervention (PCI) is often performed to reduce symptoms. Whether this i…
Among patients with stable angina, percutaneous coronary intervention (PCI) is often performed to reduce symptoms. Whether this intervention is effective without the use of background antianginal medication is unknown. Full ORBITA-2 Research Summary: https://t.co/o23lFeHgWA
Abstractしか読んでないけど、PCIとplacebo procedure のcontrolled trialって、どうやって参加を募るんだろ?日本だと成り立ちそうにないなぁ。 https://t.co/S9w7bnVpya
RT @AAlMohammad87: #ORBITA_2 @NEJM @rallamee @ProfDFrancis @ncurzen Marvellous proof by placebo controlled trial: #PCI relieves angina only…
RT @AAlMohammad87: #ORBITA_2 @NEJM @rallamee @ProfDFrancis @ncurzen Marvellous proof by placebo controlled trial: #PCI relieves angina only…
RT @AAlMohammad87: #ORBITA_2 @NEJM @rallamee @ProfDFrancis @ncurzen Marvellous proof by placebo controlled trial: #PCI relieves angina only…
#ORBITA_2 @NEJM @rallamee @ProfDFrancis @ncurzen Marvellous proof by placebo controlled trial: #PCI relieves angina only 46 years after first PCI (16/09/1977 #Gruüntzig) @mmamas1973 @drandrewsharp @alex_rothman @MAetesam @ShefUni_ClinMed #CardioTwitter https://t.co/WyYmOXtyR6
Among patients with stable angina who were receiving little or no antianginal medication and had objective evidence of ischemia, PCI resulted in a lower angina symptom score than a placebo procedure https://t.co/ei6GNv0pvc
SAにPCIの逆襲、、、か? https://t.co/5Ge5qCozSl
久しぶりにPCI推しの論文。 でも実臨床に則していないので参考程度かな。 A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina | NEJM https://t.co/MCRs9pa1RD
Mejores trabajos científicos 2023? ECLS SHOCK en SCA
RT @NEJM: Original Article: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2) https://t.co/o23l…
RT @NEJM: Original Article: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2) https://t.co/o23l…
RT @NEJM: Original Article: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2) https://t.co/o23l…
RT @NEJM: Original Article: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2) https://t.co/o23l…
El cateterismo terapéutico es efectivo en reducir los síntomas de angina y mejorar la calidad de vida. #ORBITA2 https://t.co/MSNd1t838w https://t.co/1Jskh6CO6m
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina | NEJM https://t.co/ny3X9w3YzS
RT @NEJM: Original Article: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2) https://t.co/o23l…
RT @NEJM: Original Article: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2) https://t.co/o23l…
RT @NEJM: Original Article: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2) https://t.co/o23l…
RT @NEJM: Original Article: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2) https://t.co/o23l…
RT @NEJM: Original Article: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2) https://t.co/o23l…
Original Article: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2) https://t.co/o23lFeHgWA Editorial: Changing the Orbit around Percutaneous Coronary Intervention for Stable Angina https://t.co/4MiSm48LVa
RT @OPCILive: WATCH NOW! This week on OPCI Journal Club: “A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angi…
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina https://t.co/bDM8koT6FT
RT @OPCILive: WATCH NOW! This week on OPCI Journal Club: “A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angi…
RT @OPCILive: WATCH NOW! This week on OPCI Journal Club: “A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angi…
RT @OPCILive: WATCH NOW! This week on OPCI Journal Club: “A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angi…
RT @OPCILive: WATCH NOW! This week on OPCI Journal Club: “A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angi…
RT @OPCILive: WATCH NOW! This week on OPCI Journal Club: “A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angi…
RT @OPCILive: WATCH NOW! This week on OPCI Journal Club: “A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angi…
WATCH NOW! This week on OPCI Journal Club: “A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina" presented by @rallamee and @rajkumar_chris. Esteemed panelists @DrAllenJ @ziadalinyc @djc795 and @DoosupShin. https://t.co/g9OltqFw7D https://t.co/5jiNLRCY02
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina | NEJM Another COURAGE trial
2 min cardiology(臨床論文、担当:羽尾清貴) A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina C A Rajkumar et al. NEJM 2023 DOI: 10.1056/NEJMoa2310610 #Cardiology #Intervention →
RT @DFCapodanno: ORBITA-2, the revenge. In a randomized, placebo-controlled trial of 301 patients with stable angina who stopped all antian…
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina
RT @NEJM: @AHAScience A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2): https://t.co/o23lFeHgW…
【安定狭心症の症状軽減にもPCIが有効(NEJM)】 OBRITA-2試験。安定狭心症301人(79%男性)RCT。PCI vs プラセボで12週間の追跡でで狭心症症状スコア 2.9 vs 5.6点とオッズ比2.21 (1.41-3.47)。 https://t.co/vfhxV7rCz3 https://t.co/ok2Qged6z5
RT @2minmed: #VisualAbstract: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina https://t.co/xVpjLeo91X #S…
Finally!!! A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina | NEJM https://t.co/UUXYtXUK0y
RT @ZHeart11768530: #AHA23: 4 Original Articles (#SELECT, #MINT, #ORBITA-2 & #ARTESIA) were simultaneously published @NEJM & presented @ #A…
RT @NEJM: @AHAScience A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2): https://t.co/o23lFeHgW…
RT @VipsMDMEd: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina | NEJM https://t.co/2ikrJt4WhC
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina | NEJM https://t.co/2ikrJt4WhC
#VisualAbstract: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina https://t.co/xVpjLeo91X #StudyGraphics #antianginalmedication https://t.co/OshxWiCOq4
RT @ZHeart11768530: @NEJM Bookmark this post for future reference.@NEJM 3. A Placebo-Controlled Trial of Percutaneous Coronary Intervention…
RT @NEJM: @AHAScience A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2): https://t.co/o23lFeHgW…
@NEJM Bookmark this post for future reference.@NEJM 3. A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2): https://t.co/yrdFsI74Gf 4. Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation (ARTESIA): https://t.co/MPElv3feCF https://t.co/fF6KpzZtw1
@AHAScience A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2): https://t.co/o23lFeHgWA https://t.co/O5oXMMogAf
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina #science #publication #research #journal https://t.co/v793PRbeq6
Imperial’s got talent: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina https://t.co/8m6sCiNtLy, Dr Rasha Al-Lamee https://t.co/ZQjRxZfJiY
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina | NEJM https://t.co/5lHJlwJo7o
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina. Probably the first time a mechanistic (as much as clinical trials allow) explanation is given for coronary stenosis as cause of angina. Congratulations to the authors https://t.co/lhR7ifaZTr
RT @medical_xpress: Heart stents may offer alternative to #chestPain medication for angina #patients @imperialspark @nejm https://t.co/j3mn…
RT @DrDamluji: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina: @NEJM ORBITA-II Great research from…
RT @medical_xpress: Heart stents may offer alternative to #chestPain medication for angina #patients @imperialspark @nejm https://t.co/j3mn…
RT @medical_xpress: Heart stents may offer alternative to #chestPain medication for angina #patients @imperialspark @nejm https://t.co/j3mn…
RT @medical_xpress: Heart stents may offer alternative to #chestPain medication for angina #patients @imperialspark @nejm https://t.co/j3mn…
RT @medical_xpress: Heart stents may offer alternative to #chestPain medication for angina #patients @imperialspark @nejm https://t.co/j3mn…
Heart stents may offer alternative to #chestPain medication for angina #patients @imperialspark @nejm https://t.co/j3mncE1Ngb https://t.co/Bm7GINOQGW
PCIでdouble-blind randomized-placebo controlled 試験。日本でもここまで気合入れないと、エビデンスと言われないんでしょうか。 A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina | NEJM https://t.co/Ao20AxTQGo
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina #science #publication #research #publications https://t.co/gc7hdmhvH1
RT @NEJM: Original Article: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2 trial) https://t.c…
RT @ValleAlfonso: ⚠️⚠️ORBITA-2
RT @NEJM: Original Article: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2 trial) https://t.c…
RT @NEJM: Original Article: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2 trial) https://t.c…
RT @NEJM: Original Article: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2 trial) https://t.c…
RT @NEJM: Original Article: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2 trial) https://t.c…
RT @NEJM: Original Article: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2 trial) https://t.c…
RT @NEJM: Original Article: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2 trial) https://t.c…
Original Article: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina (ORBITA-2 trial) https://t.co/o23lFeHgWA #AHA23 @AHAScience https://t.co/QTk9UJhJ2G
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina | NEJM https://t.co/lVOJz3JABf
RT @ValleAlfonso: ⚠️⚠️ORBITA-2
RT @ValleAlfonso: ⚠️⚠️ORBITA-2
RT @SeguraCardio:
RT @SABOURETCardio: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina #ORBITA2 #AHA23 #PCI https://t.co/d…
RT @MGtberg: Huge congratulations to the investigators for this seminal trial demonstrating the level of benefit of PCI in CCS. @rallamee @…
RT @ValleAlfonso: ⚠️⚠️ORBITA-2
RT @SeguraCardio:
RT @DrAhranArnold: ORBITA-2: PCI does improve symptoms in stable angina. A Placebo-Controlled Trial of Percutaneous Coronary Intervention…
RT @ValleAlfonso: ⚠️⚠️ORBITA-2
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina | NEJM https://t.co/aasy5YUj3P
RT @MGtberg: Huge congratulations to the investigators for this seminal trial demonstrating the level of benefit of PCI in CCS. @rallamee @…
RT @DrAhranArnold: ORBITA-2: PCI does improve symptoms in stable angina. A Placebo-Controlled Trial of Percutaneous Coronary Intervention…
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina: @NEJM ORBITA-II Great research from @AHA_Research #AHA23 Summary
DC
FP